GenomeNext LLC — Form D
GenomeNext LLC of COLUMBUS, OH, a company, filed a Form D exempt-offering notice with the SEC on 2016-02-26. The offering totals $1.0M, of which $1.0M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2016-02-26
- Form: D
- Accession: 0001667959-16-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $1.0M
- Amount sold: $1.0M
- Investors: 3
- Date of first sale: 2016-02-17
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-258192
Issuer
- Name: GenomeNext LLC
- CIK: 0001667959
- Entity type: Limited Liability Company
- Jurisdiction: OHIO
- Incorporated: 2014
- Address: 175 SOUTH 3RD STREET, SUITE 200, COLUMBUS, OH, 43215
- Phone: 301-275-8080
Officers, directors & promoters (5)
| Name | Role | Location |
|---|
| Hemant Datta | Director | Columbus, OH |
| Craig Atkinson | Director | Columbus, OH |
| Drew Conway | Director | Columbus, OH |
| James Hirmas | Director | Columbus, OH |
| James Hirmas | Executive Officer | Columbus, OH |
Other filings by this issuer (1)
More